Pancreas Flashcards
solid pancreatic neoplasms
ductal adenocarcinoma, acinar cell carcinoma
cystic epithelial neoplasms
serous cystic, mucinous cystic, SPEN, IPMN
endocrine epithelial neoplasms
insulinoma, gastrinoma, glucagonoma, VIPoma, somatostatinoma
most common pancreatic tumor
ductal adenocarcinoma
pancreatic ductal adenocarcinoma
patients > 60, mostly male
risks: smoking, alcohol, chronic pancreatitis
pancreatic ductal adenocarcinoma imaging findings
pancreatic mass, most comspicuous on late arterial phase for a hypoenhancing tumor
usually in pancreatic head; ductal dilation, double duct sign
T1 hypointense, ill defiend hypovascular mass
pancreatic ductal dilation ddx
autoimmune panceatitis, groove pancreatitis, cystic pancreatic tumor, neuroendocrine tumor, duodenal GIST, peripancreatic LN, pancreatic met (RCC, thyroid, melanoma), lymphoma
unresectable vs resectable pancreatic ductal adenocarcinoma
unresectable: encasement >180 degrees of SMA, venous invasion, or mets
resectable: no celiac/SMA, portal vein invasion; limited extension to duodenum/stomach/CBD
acinar cell carcinoma
rare aggressive variant of pancreatic adenocarcinoma
exclusive in elderly males
lipase hypersecretion syndrome
subcutaneous fat necrosis, bone infarcts (polyarthralgia), eosinophilia
seen in acinar cell carcinoma in which large amount of lipase is present
serous cystadenoma
grandmother tumor
many small cysts that may have a solid appearance on CT; hypervascular
does not cause pancreatic duct dilation or tail atrophy
central stellate calcification
mucinous cystic neoplasm
mother tumor
single or few large cysts >2 cm; typically in body/tail
has a capsule (similar to SPEN)
treatment of mucinous cystic neoplasm
resection due to malignant potential
SPEN
daughter tumor; young women/children
large mass with heterogenous solid/cystic area; hemorrhage typical; capsule (similar to mucinous cystic neoplasm)
IPMN
grandfather tumor; elderlym men (although large age/sex variability)
sidebranch vs main duct (more malignant); nodular/enhancing component most concerning for malignancy
IPMN view on endoscopy
fish mouth papilla pouring out mucin; lesion contiguous with duct/sidebranch
IPMN treatment/followup
follow-up: simple cysts <1 cm followed annually
treatment: resect if >3 cm in size, mural nodule, or dilation of pancreatic duct >1 cm
pancreatic neuroendocrine tumor types
hyperfunctioning vs nonfunctioning (larger at diagnosis; mimic cystic neoplasms, central necrosis/calcification)
typically hypervascular; solid unless large
hypervascular liver mass with associated pancreatic mass, likely metastatic PNET
hyperfunctioning PNET tumors
insulinoma, gastrinoma, glucagonoma, VIPoma, somatostatinoma
most common PNET
insulinoma
insulinoma
hypoglycemia; present early and have best prognosis